NCT06621017: An ongoing trial by Rose Pharma Inc
This trial is ongoing. It must report results 2 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06621017 |
|---|---|
| Title | A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Daily Administrations of the GLP-1 Analogue ROSE-010 on Appetite and Food Intake in Overweight and Obese Subjects |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 26, 2024 |
| Completion date | Feb. 27, 2025 |
| Required reporting date | Feb. 27, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |